Infants Lacking Vitamin K Show Higher Bleeding Risks

Infants in Sweden who did not receive intramuscular vitamin K at birth demonstrated a higher risk of bleeding episodes, including intracranial hemorrhage. This finding emerged from a nationwide study analyzing data from 1990 to 2018, encompassing over 2.7 million infants. The research, published in JAMA Pediatrics, identified a statistically significant association between the absence of vitamin K prophylaxis and an increased incidence of bleeding events.

The study specifically highlighted a higher rate of vitamin K deficiency bleeding (VKDB), a condition that can lead to severe neurological damage and even death. While the practice of administering vitamin K at birth is standard in many countries to prevent VKDB, a small but increasing number of parents in Sweden have opted out of this intervention. The researchers aimed to quantify the risks associated with this choice using comprehensive national health registries.

Researchers observed that infants who did not receive the vitamin K injection experienced approximately 4.5 times more bleeding episodes compared to those who did. This elevated risk was particularly concerning for intracranial hemorrhages, a severe form of bleeding within the brain. The study's authors emphasized that the benefits of vitamin K prophylaxis in preventing these potentially devastating outcomes far outweigh any perceived risks of the injection itself.

The findings underscore the critical role of vitamin K in neonatal hemostasis and serve as a strong recommendation for continued universal vitamin K administration at birth. The study's large sample size and nationwide scope lend significant weight to its conclusions, providing robust evidence for public health recommendations and clinical practice guidelines aimed at protecting infants from preventable bleeding disorders.